Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia
Lack of medication adherence among patients with dyslipidemia negatively affects health-related outcomes. This study aims to evaluate medication adherence; we also aim to investigate the predictors of non-adherence among patients with dyslipidemia in Jordan. Medication adherence was evaluated in a t...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-06-01
|
| Series: | Healthcare |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9032/9/7/813 |
| _version_ | 1797528544424755200 |
|---|---|
| author | Eman Alefishat Anan S. Jarab Walid Al-Qerem Lina Abu-Zaytoun |
| author_facet | Eman Alefishat Anan S. Jarab Walid Al-Qerem Lina Abu-Zaytoun |
| author_sort | Eman Alefishat |
| collection | DOAJ |
| description | Lack of medication adherence among patients with dyslipidemia negatively affects health-related outcomes. This study aims to evaluate medication adherence; we also aim to investigate the predictors of non-adherence among patients with dyslipidemia in Jordan. Medication adherence was evaluated in a total of 228 dyslipidemia patients. The Beliefs about Medicines Questionnaire was also used to assess patients’ beliefs about medications. The majority of the current study participants (73.2%) reported non-adherence to the prescribed medications. There were significant negative associations between medication adherence and concerns of prescription drug use (B = −0.41, <i>p</i>-value < 0.01), duration of dyslipidemia (B = −0.22, <i>p</i>-value < 0.01), and the number of medications (B = −0.64, <i>p</i>-value < 0.01). Positive associations were found between medication adherence and the necessity of prescription drug use (B = 0.43, <i>p</i>-value < 0.01), taking statin and fibrate (B = 2.04, <i>p</i>-value < 0.01), and moderate-intensity statin (B = 2.34, <i>p</i>-value < 0.01). As for patients’ beliefs about medications, the item “My medicine to lower my cholesterol disrupted my life” had the highest mean (3.50 ± 0.99). This study revealed a low adherence rate to medication among patients with dyslipidemia. It also demonstrates modifiable factors such as beliefs regarding perceived risk, medication harms, treatment duration, and the number of medications associated with poor adherence in patients with dyslipidemia. |
| first_indexed | 2024-03-10T09:59:52Z |
| format | Article |
| id | doaj.art-a5426ff506904e998e4af821b767a135 |
| institution | Directory Open Access Journal |
| issn | 2227-9032 |
| language | English |
| last_indexed | 2024-03-10T09:59:52Z |
| publishDate | 2021-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Healthcare |
| spelling | doaj.art-a5426ff506904e998e4af821b767a1352023-11-22T02:00:40ZengMDPI AGHealthcare2227-90322021-06-019781310.3390/healthcare9070813Factors Associated with Medication Non-Adherence in Patients with DyslipidemiaEman Alefishat0Anan S. Jarab1Walid Al-Qerem2Lina Abu-Zaytoun3Department of Pharmacology, College of Medicine and Health Science, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab EmiratesDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, JordanDepartment of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, JordanDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, JordanLack of medication adherence among patients with dyslipidemia negatively affects health-related outcomes. This study aims to evaluate medication adherence; we also aim to investigate the predictors of non-adherence among patients with dyslipidemia in Jordan. Medication adherence was evaluated in a total of 228 dyslipidemia patients. The Beliefs about Medicines Questionnaire was also used to assess patients’ beliefs about medications. The majority of the current study participants (73.2%) reported non-adherence to the prescribed medications. There were significant negative associations between medication adherence and concerns of prescription drug use (B = −0.41, <i>p</i>-value < 0.01), duration of dyslipidemia (B = −0.22, <i>p</i>-value < 0.01), and the number of medications (B = −0.64, <i>p</i>-value < 0.01). Positive associations were found between medication adherence and the necessity of prescription drug use (B = 0.43, <i>p</i>-value < 0.01), taking statin and fibrate (B = 2.04, <i>p</i>-value < 0.01), and moderate-intensity statin (B = 2.34, <i>p</i>-value < 0.01). As for patients’ beliefs about medications, the item “My medicine to lower my cholesterol disrupted my life” had the highest mean (3.50 ± 0.99). This study revealed a low adherence rate to medication among patients with dyslipidemia. It also demonstrates modifiable factors such as beliefs regarding perceived risk, medication harms, treatment duration, and the number of medications associated with poor adherence in patients with dyslipidemia.https://www.mdpi.com/2227-9032/9/7/813adherencedyslipidemiastatin |
| spellingShingle | Eman Alefishat Anan S. Jarab Walid Al-Qerem Lina Abu-Zaytoun Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia Healthcare adherence dyslipidemia statin |
| title | Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia |
| title_full | Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia |
| title_fullStr | Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia |
| title_full_unstemmed | Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia |
| title_short | Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia |
| title_sort | factors associated with medication non adherence in patients with dyslipidemia |
| topic | adherence dyslipidemia statin |
| url | https://www.mdpi.com/2227-9032/9/7/813 |
| work_keys_str_mv | AT emanalefishat factorsassociatedwithmedicationnonadherenceinpatientswithdyslipidemia AT anansjarab factorsassociatedwithmedicationnonadherenceinpatientswithdyslipidemia AT walidalqerem factorsassociatedwithmedicationnonadherenceinpatientswithdyslipidemia AT linaabuzaytoun factorsassociatedwithmedicationnonadherenceinpatientswithdyslipidemia |